Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pilar Escribano

Showing results (61-70 of 346) with videos related to

Pageof 35
Sort By:
Antimicrobial Agents and Chemotherapy|October 19, 2011
In vitro acquisition of secondary azole resistance in Aspergillus fumigatus isolates after prolonged exposure to itraconazole: presence of heteroresistant populationsPilar Escribano, Sandra Recio, Teresa Peláez, et al.
Journal of Clinical Microbiology|July 27, 2016
Correction for Guinea et al., Aspergillus citrinoterreus, a New Species of Section Terrei Isolated from Samples of Patients with Nonhematological Predisposing ConditionsJesús Guinea, Marcelo Sandoval-Denis, Pilar Escribano, et al.
Antimicrobial Agents and Chemotherapy|November 2, 2016
Frequency of the Paradoxical Effect Measured Using the EUCAST Procedure with Micafungin, Anidulafungin, and Caspofungin against Candida Species Isolates Causing CandidemiaLaura Judith Marcos-Zambrano, Pilar Escribano, Carlos Sánchez-Carrillo, et al.
The Journal of Antimicrobial Chemotherapy|February 9, 2017
The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida sppLaura Judith Marcos-Zambrano, Marta Gómez-Perosanz, Pilar Escribano, et al.
Pulmonary Circulation|April 9, 2019
Ambrisentan for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH)Pilar Escribano-Subias, Hakim Bendjenana, Paula S Curtis, et al.
Mycoses|October 28, 2022
Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu latoJulia Serrano-Lobo, Ana Gómez, Elena Reigadas, et al.
Medical Mycology|September 12, 2018
Does the composition of polystyrene trays affect Candida spp. biofilm formation?Judith Díaz-García, Laura Judith Marcos-Zambrano, Patricia Muñoz, et al.
Journal of Clinical Microbiology|April 26, 2013
Endemic genotypes of Candida albicans causing fungemia are frequent in the hospitalPilar Escribano, Marta Rodríguez-Créixems, Carlos Sánchez-Carrillo, et al.
Antimicrobial Agents and Chemotherapy|June 22, 2016
Erratum for Marcos-Zambrano et al., Comparison between the EUCAST Procedure and the Etest for Determination of the Susceptibility of Candida Species Isolates to MicafunginLaura Judith Marcos-Zambrano, Pilar Escribano, Cristina Rueda, et al.
The Journal of Antimicrobial Chemotherapy|June 20, 2014
Micafungin is more active against Candida albicans biofilms with high metabolic activityLaura Judith Marcos-Zambrano, Pilar Escribano, Marcela González del Vecchio, et al.
Pageof 35

Showing results (61-70 of 346) with videos related to

Sort By:
Pageof 35
Antimicrobial Agents and Chemotherapy|October 19, 2011
In vitro acquisition of secondary azole resistance in Aspergillus fumigatus isolates after prolonged exposure to itraconazole: presence of heteroresistant populationsPilar Escribano, Sandra Recio, Teresa Peláez, et al.
Journal of Clinical Microbiology|July 27, 2016
Correction for Guinea et al., Aspergillus citrinoterreus, a New Species of Section Terrei Isolated from Samples of Patients with Nonhematological Predisposing ConditionsJesús Guinea, Marcelo Sandoval-Denis, Pilar Escribano, et al.
Antimicrobial Agents and Chemotherapy|November 2, 2016
Frequency of the Paradoxical Effect Measured Using the EUCAST Procedure with Micafungin, Anidulafungin, and Caspofungin against Candida Species Isolates Causing CandidemiaLaura Judith Marcos-Zambrano, Pilar Escribano, Carlos Sánchez-Carrillo, et al.
The Journal of Antimicrobial Chemotherapy|February 9, 2017
The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida sppLaura Judith Marcos-Zambrano, Marta Gómez-Perosanz, Pilar Escribano, et al.
Pulmonary Circulation|April 9, 2019
Ambrisentan for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH)Pilar Escribano-Subias, Hakim Bendjenana, Paula S Curtis, et al.
Mycoses|October 28, 2022
Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu latoJulia Serrano-Lobo, Ana Gómez, Elena Reigadas, et al.
Medical Mycology|September 12, 2018
Does the composition of polystyrene trays affect Candida spp. biofilm formation?Judith Díaz-García, Laura Judith Marcos-Zambrano, Patricia Muñoz, et al.
Journal of Clinical Microbiology|April 26, 2013
Endemic genotypes of Candida albicans causing fungemia are frequent in the hospitalPilar Escribano, Marta Rodríguez-Créixems, Carlos Sánchez-Carrillo, et al.
Antimicrobial Agents and Chemotherapy|June 22, 2016
Erratum for Marcos-Zambrano et al., Comparison between the EUCAST Procedure and the Etest for Determination of the Susceptibility of Candida Species Isolates to MicafunginLaura Judith Marcos-Zambrano, Pilar Escribano, Cristina Rueda, et al.
The Journal of Antimicrobial Chemotherapy|June 20, 2014
Micafungin is more active against Candida albicans biofilms with high metabolic activityLaura Judith Marcos-Zambrano, Pilar Escribano, Marcela González del Vecchio, et al.
Pageof 35